Bradley Merrill Thompson serves as Chairman of the Board of EBG Advisors, Inc.  Mr. Thompson has more than 30 years of experience working with medical device, drug, and combination product companies on a wide range of FDA regulatory and reimbursement issues.  For trade associations, Mr. Thompson has served as counsel to AdvaMed and the Continua Health Alliance; as General Counsel to the Combination Products Coalition, mHealth Regulatory Coalition, and the CDS Coalition; and as General Counsel and Secretary for the Indiana Medical Device Manufacturers Council (“IMDMC”).

Representative Experience

Over the years, Mr. Thompson has focused on the best ways for agencies and the public to work together in defining new regulatory policy and guidance. On behalf of the IMDMC and several large trade associations representing virtually every industry that FDA regulates, in the mid-1990s, Mr. Thompson advocated that FDA should improve its guidance development process to enhance the quality and reliability of guidance as well as to better ensure public participation. Mr. Thompson’s advocacy resulted in the so-called FDA Good Guidance Practices, now embraced by other federal agencies as well. In the late 1990s, Mr. Thompson successfully advocated that what is now called the Centers for Medicare & Medicaid Services should conduct its coverage decision-making process more openly and, in particular, should permit public attendance at its advisory committee meetings.

Memberships & Affiliations

  • American Bar Association
  • American Bar Foundation, Fellow
  • Food and Drug Law Institute
  • Regulatory Affairs Professional Society


Mr. Thompson was elected by his peers as a Fellow of the American Bar Association, and he has received an "AV Preeminent" Peer Review Rating by Martindale-Hubbell, signifying the highest level of professional excellence. He was included in 100 Notable People in the Medical Device Industry (Medical Device & Diagnostics Industry, June 2004) and has been listed in Chambers USA: America's Leading Lawyers for Business (2010 to 2016). He was selected by his peers for inclusion in The Best Lawyers in America© (2015 to 2017) in the field of FDA Law and included on the Indiana Super Lawyers list (2004 to 2006) and Washington DC Super Lawyers list (2013 to 2016) in the areas of Food and Drugs, Administrative Law, and Health Care. Additionally, Mr. Thompson was recommended in the Life Sciences category by The Legal 500 United States (2014).


  • University of Michigan Law School  (J.D., cum laude)
  • University of Illinois  (M.B.A.)
  • University of Illinois  (B.A., cum laude)